Over time, significant strides have been made in immune checkpoint research, resulting in the discovery of several inhibitory (LAG-3, TIM-3, TIGIT, VISTA and B7-H3) and stimulatory receptors (OX40, ICOS, GITR, 4-1BB and CD40), which are being investigated as potential targets for therapy development. Further, studies of combinatorial immune checkpoint blockade / co-stimulation, targeting newly identified checkpoints along with known checkpoint inhibitor therapies, have demonstrated promising…

Roots Analysis has done a detailed study on Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 350+ page report, which features 140+ figures and 170+ tables, please visit this -…

Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions

Roots Analysis is pleased to announce the publication of its recent study, titled, “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030.”

The report features an extensive study of the current market landscape,…

To order this detailed 245+ page report, please visit this - https://www.rootsanalysis.com/reports/collaborative-robots-market.html

Key Inclusions

 An overview of the current market landscape of cobots, providing information on the market availability (available and under development), industrial task(s) performed (air blowing / spraying, CNC machine tending, gluing / dispensing / welding,…

Collaborative robots or cobots allow companies to automate their processes, are easy to program and deploy, can increase productivity manifolds, and offer high returns on investment. It is worth noting that, according to the International Federation of Robotics (IFR), over time, the cost of cobots has decreased owing to growing demand for such machines across various industries, including automobiles, electronics / electrical goods, food and beverages, as well as life sciences /…

Roots Analysis has done a detailed study on Global Collaborative Robots (Cobots) Market, 2020-2030.”

, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 245+ page report, which features 80+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/collaborative-robots-market.html

Key Market…

Given their flexibility and price to functionality ratio, cobots represent an ideal entry-level, automation model for both small and established companies, which do not intend to make very heavy large investments in automation

Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Collaborative Robots (Cobots) Market, 2020-2030.”

The report features an extensive study of the potential applications, current landscape and the likely adoption of…

To order this detailed 250+ page report, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

Key Inclusions

 A detailed assessment of the current market landscape of companies offering drug repurposing services based on several relevant parameters, including year of establishment, company size, location of headquarters, type of company, type of…

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).

To order this 250+ page report, which…

Roots Analysis has done a detailed study on Drug Repurposing Service Providers Market, 2020-2030. covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 250+ page report, which features 100+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

Key Market…

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.”

The report features an extensive study of the current market landscape and future opportunities for…

To order this detailed 400+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html

Key Inclusions

 An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters, such as status of development (developed and…

The concept of BBB penetration is anticipated to bring about a paradigm shift in modern healthcare. In fact, experts believe that there is an important relationship between the recent pandemic of Coronavirus disease (COVID-19) and cerebrovascular system, presenting commercial opportunities for players engaged in the development of BBB penetrating drugs.

To order this 400+ page report, which features 145+ figures and 205+ tables, please visit this -…

Roots Analysis has done a detailed study on Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics.”

covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 400+ page report, which features 145+ figures and 205+ tables, please visit this -…

Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries

Roots Analysis is pleased to announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics.”

The…

To order this detailed 300+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html

Key Inclusions

 A detailed review of the overall landscape of companies offering contract services for manufacturing of microbiome therapeutics, including information on year of establishment, company size, scale of…

Manufacturing live biotherapeutic products is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.

To order this 300+ page report, which features 140+ figures and 125+ tables, please visit this -…

Roots Analysis has done a detailed study on Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 300+ page report, which features 140+ figures and 125+ tables, please visit this -…

Manufacturing live biotherapeutic product is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.

Roots Analysis is pleased to announce the publication of its recent study, titled, “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage…

With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand for R&D and manufacturing services for such products is anticipated to increase beyond the capabilities of innovator companies alone

London

Roots Analysis has announced the addition of “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030” report to…